Minerva Surgical Analysis

Minerva Pink Sheet Analysis Notes

About 90.0% of the company outstanding shares are owned by institutional investors. The company has Price to Book (P/B) ratio of 0.51. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Minerva Surgical recorded a loss per share of 7.61. The entity had not issued any dividends in recent years. The firm had 1:20 split on the 2nd of October 2023. Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company was incorporated in 2008 and is headquartered in Santa Clara, California. Minerva Surgical operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 157 people.The quote for Minerva Surgical is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more information please call David Clapper at 855 646 7874 or visit https://minervasurgical.com.

Minerva Surgical Investment Alerts

Minerva Surgical Upcoming and Recent Events

Minerva Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 13.14 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Minerva Surgical's market, we take the total number of its shares issued and multiply it by Minerva Surgical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Minerva Profitablity

The company has Profit Margin (PM) of (0.65) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.51) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.51.

Minerva Surgical Insider Trading Activities

Minerva Surgical Outstanding Bonds

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

If you are still planning to invest in Minerva Surgical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Minerva Surgical's history and understand the potential risks before investing.